“4-Company Oligopoly” on Seasonal Flu Vaccines Coming to an End, Era of Mega-Competition Coming to Japan: Dr Yamanishi of BIKEN

BIKEN Director Koichi Yamanishi Japanese vaccine manufacturers will be unable to survive if they fail to invest resources in R&D and launch competitively superior new vaccines, said Koichi Yamanishi, director of the Research Foundation for Microbial Diseases of Osaka University...read more